Investor mix
9 investors on record; lead investors include Aberdare Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 1 | 11% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 1 | 11% |
Discovers and develops small molecule therapeutics for autoimmune and cardiovascular diseases.
9 investors on record; lead investors include Aberdare Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 1 | 11% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 1 | 11% |